Loading…
biote Corp. is projected to rise to $3.34 by 2027, a +48% move from its current price of $2.25. BTMD is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $2.15 | $2.25 | $2.35 | -0.03% |
| Aug 6 | $2.11 | $2.25 | $2.39 | -0.05% |
| Aug 7 | $2.09 | $2.25 | $2.42 | -0.08% |
| Aug 8 | $2.06 | $2.25 | $2.45 | -0.10% |
| Aug 9 | $2.04 | $2.25 | $2.48 | -0.13% |
| Aug 10 | $2.02 | $2.25 | $2.50 | -0.16% |
| Aug 11 | $2.00 | $2.25 | $2.52 | -0.18% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.00 | $2.25 | $2.52 | -0.18% |
| Week 2 | $1.91 | $2.24 | $2.64 | -0.37% |
| Week 3 | $1.83 | $2.24 | $2.73 | -0.55% |
| Week 4 | $1.77 | $2.23 | $2.81 | -0.73% |
| Week 5 | $1.72 | $2.23 | $2.88 | -0.91% |
| Week 6 | $1.68 | $2.23 | $2.95 | -1.09% |
| Week 7 | $1.64 | $2.22 | $3.01 | -1.28% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Biote Corp. operates in the practice-building space within the hormone optimization field. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance.
Biote Method provides an end-to-end platform for Biote-certified practitioners, including education, training, and certification; practice management software to order, track, and manage hormone optimization product inventory and meet administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support.
The company also sells dietary supplements under the Biote brand and sterile pellet insertion kits used with hormone optimization therapies for male and female patients. Biote Corp. was founded in 2012 and is headquartered in Irving, Texas.
Biote Corp., BTMD, operates in Healthcare and has a current price of $2.22 with a market cap of $78.93M, ranking 4058 by market cap.
The stock trades near key moving averages, with SMA50 at $2.19 and SMA200 at $2.25, indicating a price that is close to short- and long-term averages.
On the chart, there is support at $1.67 and resistance at $2.52, with a 30-day range of $1.65 to $2.98. The stock exhibits an annualized volatility of 90%.
Forecasts project a long-run price path with 2026 avg near current levels ($2.22), rising through 2027 ($3.36 avg) and 2028 ($3.74 avg), and continuing higher toward 2030 ($4.39 avg), 2040 ($11.12 avg), and 2050 ($20.50 avg), accompanied by rising ROIs (e.g., 97.7% in 2030, 400.8% in 2040, and 823.2% in 2050) and bullish sentiment in later years.
A major floor 42.4% below — a decisive break under it would weaken the trend.
The nearest floor, 25.8% below — buyers have tended to step in here.
The nearest ceiling, 12.0% above — a clean break opens room to run.
A major ceiling 33.2% above — clearing it would confirm fresh momentum.
Key BTMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BTMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.22 | Buy | $2.23 | Buy |
| MA 10 | $2.30 | Sell | $2.25 | Sell |
| MA 20 | $2.29 | Sell | $2.25 | Sell |
| MA 50 | $2.19 | Buy | $2.20 | Buy |
| MA 100 | $2.01 | Buy | $2.18 | Buy |
| MA 200 | $2.25 | Buy | $2.41 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.47 | Neutral |
| Stoch RSI (14) | 40.70 | Neutral |
| CCI (20) | -35.57 | Neutral |
| Williams %R (14) | -56.25 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | 3.69 | Buy |
| Bollinger %B (20,2) | 0.40 | Neutral |
| Stochastic %K (14) | 43.75 | Neutral |
| TRIX (15) | 0.25 | Buy |
| Awesome (5,34) | 0.00 | Buy |
| Ultimate (7,14,28) | 45.06 | Neutral |
| Momentum (10) | -0.18 | Sell |
| Aroon Osc (25) | 60.00 | Buy |
| Hull MA (9) | 2.14 | Buy |
| ADX (14) | 10.85 | Neutral |
| ATR (14) | 0.09 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 50.
SMA50 is $2.19 and SMA200 is $2.25, indicating prices hovering near nearby short- and long-term averages.
Key support is at $1.67 and resistance at $2.52, and the 30-day trading range spans from $1.65 to $2.98. The asset shows an annualized volatility of 90%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.30 | $2.25 | $2.76 | 0% | Neutral | |
| $2.52 | $3.34 | $4.75 | +48% | Bullish | |
| $2.70 | $3.75 | $5.64 | +67% | Bullish | |
| $2.67 | $3.87 | $6.07 | +72% | Bullish | |
| $2.89 | $4.34 | $7.05 | +93% | Bullish | |
| $2.76 | $4.28 | $7.17 | +90% | Bullish | |
| $2.85 | $4.56 | $7.85 | +103% | Bullish | |
| $3.25 | $5.36 | $9.45 | +138% | Bullish | |
| $4.01 | $6.80 | $12.26 | +202% | Bullish | |
| $4.62 | $8.07 | $14.84 | +259% | Bullish | |
| $5.45 | $10.85 | $21.71 | +382% | Bullish | |
| $8.94 | $19.87 | $44.78 | +783% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.30 | $2.25 | $2.59 | +0.00% |
| September 2026 | $1.75 | $2.10 | $2.63 | -6.57% |
| October 2026 | $1.81 | $2.20 | $2.79 | +4.51% |
| November 2026 | $1.76 | $2.16 | $2.78 | -1.66% |
| December 2026 | $1.71 | $2.12 | $2.76 | -1.83% |
Click any year to see its month-by-month BTMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect BTMD to range from $1.30 to $2.76 through 2026. The $2.25 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The BTMD price prediction for 2027 points to an average of $3.34 (low $2.52, high $4.75) — a potential gain of +48% on today's $2.25. Buyers look set to stay in control over this stretch.
In 2028, BTMD is projected to trade between $2.70 and $5.64, averaging $3.75 — a potential gain of +67% from today's $2.25. That is up +12% on the projected 2027 average. Momentum favours further upside here.
biote Corp.'s 2029 outlook centres on $3.87, within a $2.67 to $6.07 range. That is up +3% on the projected 2028 average. That marks a +72% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, BTMD could reach as high as $7.05, with a base case around $4.34 and support toward $2.89 — roughly +93% from $2.25. Momentum favours further upside here.
Expect BTMD to range from $2.76 to $7.17 through 2031. The $4.28 average target implies a +90% move from current prices. That is -1% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
The BTMD price prediction for 2032 points to an average of $4.56 (low $2.85, high $7.85) — a potential gain of +103% on today's $2.25. Momentum favours further upside here.
In 2033, BTMD is projected to trade between $3.25 and $9.45, averaging $5.36 — a potential gain of +138% from today's $2.25. That is up +17% on the projected 2032 average. Buyers look set to stay in control over this stretch.
biote Corp.'s 2034 outlook centres on $6.80, within a $4.01 to $12.26 range. That is up +27% on the projected 2033 average. That marks a +202% change versus current levels. Momentum favours further upside here.
By 2035, BTMD could reach as high as $14.84, with a base case around $8.07 and support toward $4.62 — roughly +259% from $2.25. Buyers look set to stay in control over this stretch.
Expect BTMD to range from $5.45 to $21.71 through 2040. The $10.85 average target implies a +382% move from current prices. That is up +35% on the projected 2035 average. Momentum favours further upside here.
The BTMD price prediction for 2050 points to an average of $19.87 (low $8.94, high $44.78) — a potential gain of +783% on today's $2.25. Buyers look set to stay in control over this stretch.
Investing $1,000 in BTMD today (≈ 444.444444 BTMD) could be worth
$8,831.21
+$7,831.21 (+783%) by 2050 · US Dollar
Based on the average projected BTMD price of $19.87 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BTMDwould be worth at today's price.
$1,000 invested in BTMD on Jul 31, 2025 (≈ 245.700235 BTMD) would be worth
$552.83
-$447.17 (-44.7%) today · 0.55× · US Dollar
Based on a BTMD entry price of $4.07 vs. today's $2.25.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.28 | $986.84 | -1.3% |
| 1 month ago | $1.99 | $1,130.65 | +13.1% |
| 3 months ago | $2.19 | $1,027.4 | +2.7% |
| 6 months ago | $2.27 | $991.19 | -0.9% |
| 1 year ago | $4.07 | $552.83 | -44.7% |
| All time (5.0y) ago | $9.71 | $231.72 | -76.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BTMD forecast.
Our base-case forecast reaches $4.50 around 2032.
Implied market cap at $4.50: $136.49M
In 2030, the forecasted average price is $4.39 with a min of $2.90 and a max of $7.19, and the ROI is 97.7% with bullish sentiment.
For 2040, the forecast shows an average of $11.12, a min of $5.47 and a max of $22.51, with a 400.8% ROI and bullish sentiment.
By 2050, the forecast calls for an average of $20.50, a min of $9.22 and a max of $46.84, with an ROI of 823.2% and bullish sentiment.
These are estimates and not guarantees, and outcomes depend on market conditions and other factors. If market dynamics shift, the actual path could differ from the projections.
Tap a question to reveal the answer.
2030 avg $4.39; min $2.90; max $7.19; ROI 97.7%; sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward, with 2030–2050 price trajectory and ROIs up to 823.2%, though 2026 shows 0% ROI. These are estimates, not guarantees.
2033 max $9.75; 2034 max $12.61, so the forecasted maximum by 2034 exceeds $10.
Current price is $2.22 and market cap is $78.93M.
Sentiment NEUTRAL; RSI14 50; SMA50 $2.19; SMA200 $2.25; support $1.67; resistance $2.52; 30-day range $1.65–$2.98.
biote Corp. Community Discussion
0Share your biote Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.